VIVS VivoSim Labs Inc.

Price (delayed)

$0.3446

Market cap

$1.2M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.35

Enterprise value

-$3.4M

?
Relative Growth: Rel. Growth: 3
Relative Strength: Rel. Strength: 0
Relative Valuation: Rel. Valuation: 10
Relative Profitability: Rel. Profitability: 15

Organovo is a clinical stage biotechnology company that is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for drug development. The company’s lead molecule, ...

Highlights
VIVS's debt is down by 47% year-on-year and by 30% since the previous quarter
VIVS's gross margin is up by 3.6% YoY
The equity has dropped by 125% since the previous quarter and by 110% year-on-year
VIVS's quick ratio is down by 33% YoY

Key stats

What are the main financial stats of VIVS

VIVS stock price

How has the VivoSim Labs stock price performed over time
Intraday
-10.73%
1 week
-17.74%
1 month
-67.79%
1 year
-81.57%
YTD
-80.96%
QTD
-67.79%

Financial performance

How have VivoSim Labs's revenue and profit performed over time
Revenue
$131,000
Gross profit
$131,000
Operating income
-$11.49M
Net income
-$13.84M
Gross margin
100%
Net margin
-10,567.2%
The operating income has grown by 9% YoY
The revenue has contracted by 9% YoY and by 8% from the previous quarter
The operating margin has declined by 9% since the previous quarter
VIVS's gross profit is down by 8% since the previous quarter and by 6% year-on-year

Price vs fundamentals

How does VIVS's price correlate with its fundamentals

Growth

What is VivoSim Labs's growth rate over time

Valuation

What is VivoSim Labs stock price valuation
P/E
N/A
P/B
N/A
P/S
6.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-25.94
The equity has dropped by 125% since the previous quarter and by 110% year-on-year
The P/S is 85% below the 5-year quarterly average of 45.2 and 81% below the last 4 quarters average of 35.4
The revenue has contracted by 9% YoY and by 8% from the previous quarter

Efficiency

How efficient is VivoSim Labs business performance

Dividends

What is VIVS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VIVS.

Financial health

How did VivoSim Labs financials performed over time
The total assets is 13% smaller than the total liabilities
The total liabilities has surged by 104% year-on-year
The total assets has declined by 50% year-on-year but it has increased by 6% since the previous quarter
VIVS's debt is 151% greater than its equity
The equity has dropped by 125% since the previous quarter and by 110% year-on-year
VIVS's debt is down by 47% year-on-year and by 30% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.